Our COVID-19 Prevention Efforts - Kisco Senior Living

Kisco COVID-19 Vaccine Update

May 21, 2021 | The choice to work in the Senior Living industry inherently includes a commitment to the safety of those we serve. Now that every state has vaccines available for all adults, it is time for us to address the need for all Kisco associates to be vaccinated. We have made the decision to require Covid-19 vaccinations for all associates. While the vast majority of our residents and associates have already been vaccinated, this decision further ensures that every Kisco resident and associate is protected to the greatest extent possible. At Kisco Senior Living, our top priority is the health and well-being of residents and associates.

Kisco COVID-19 Vaccine Statement

January 4, 2021 | Over the past nine months, close to 350,000 Americans have lost their lives due to COVID-19. Less than 1% of the US population is over 80 years of age, yet this segment represents over 40% of those who have been killed by this deadly disease. At Kisco our top priority from the beginning of the pandemic has been to keep residents and associates as safe as possible, and we are indebted to our community teams who have worked tirelessly to achieve this objective. Our communities have conducted over 50,000 Covid tests and we continue to lead the industry in efforts to minimize those affected by this horrible disease.

COVID-19 Testing Strategy

October 7, 2020 | Throughout the COVID-19 pandemic, Kisco Senior Living has kept the safety of its residents and associates its top priority. Now the senior living company is taking it one step further with an innovative approach to testing, similar to the method taken by professional sports teams. Using pooled saliva PCR testing, Kisco Senior Living is aiming to create a “safety bubble,” giving the company the confidence to open up operationally. The saliva PCR test was recently approved by the Food and Drug Administration (FDA) and will be given to all residents once a week and all associates twice a week. The company is partnering with SiREM labs for the testing and will be sending approximately 32,000 vials per month from its 20 senior living communities to the laboratory for processing.